Evaluation of chromosomal damage, cytostasis, cytotoxicity, oxidative DNA damage and their association with body-mass index in obese subjects

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 771, Issue , 2014, Pages 30-36

  Donmez Altuntas, Hamiyet ^a   Sahin, Fatma ^a   Bayram, Fahri ^a   Bitgen, Nazmiye ^a   Mert, Meral ^b   Guclu, Kenan ^a   Hamurcu, Zuhal ^a   Aribas, Sülbiye ^a   Gundogan, Kursat ^a   Diri, Halit ^a  

^a ERCIYES UNIVERSITY   (Turkey)

^b Kayseri State Hospital of Research and Education   (Turkey)

Author keywords

8 OHdG concentration; BMI; CBMN cyt assay; MN frequency; Obesity; WHR

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8-OXO-7-HYDRODEOXYGUANOSINE; DEOXYGUANOSINE;

ADULT; APOPTOSIS; ARTICLE; ASSAY; BODY MASS; CELL DEATH; CHROMOSOME DAMAGE; CONTROLLED STUDY; CYTOKINESIS; CYTOSTASIS; CYTOTOXICITY; DNA DAMAGE; FEMALE; GENETIC DAMAGE; HUMAN; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MICRONUCLEUS; NUCLEAR BUD; NUCLEOPLASMIC BRIDGE; OBESITY; OXIDATION; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; WAIST HIP RATIO; ANALOGS AND DERIVATIVES; BLOOD; CASE CONTROL STUDY; CELL CULTURE; CELL PROLIFERATION; CHROMOSOME ABERRATION; GENETICS; METABOLISM; MICRONUCLEUS TEST; MIDDLE AGED; OXIDATIVE STRESS; PATHOPHYSIOLOGY; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; CELL PROLIFERATION; CELLS, CULTURED; CHROMOSOME ABERRATIONS; DEOXYGUANOSINE; DNA DAMAGE; FEMALE; HUMANS; MALE; MICRONUCLEUS TESTS; MIDDLE AGED; OBESITY; OXIDATIVE STRESS; YOUNG ADULT;

EID: 84904400220     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2014.06.006     Document Type: Article

References (55)

1. World Health Organisation Obesity and Overweight. WHO Fact Sheet No. 311, September 2006.
2. World Health Organization. Obesity and Overweight. Available from: (updated March 2013; cited 09.07.13). http://www.who.int/mediacentre/factsheets/fs311/en/.
3. World Health Organisation WHO Technical Report Series 894. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation 2000, World Health Organization, Geneva.
4. World Health Organization. BMI Classification in Global Database on Body Mass Index. Available from: (updated 10.07.13; cited 10.07.13). http://apps.who.int/bmi/index.jsp%3FintroPage=intro_3.html.
5. Flegal K.M., Graubard B.I., Williamson D.F., Gail M.H. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 2007, 298:2028-2037.
6. Adams K.F., Schatzkin A., Harris T.B., Kipnis V., Mouw T., Ballard-Barbash R., Hollenbeck A., Leitzmann M.F. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N. Engl. J. Med. 2006, 355:763-778.
7. Jee S.H., Sull J.W., Park J., Lee S.Y., Ohrr H., Guallar E., Samet J.M. Body-mass index and mortality in Korean men and women. N. Engl. J. Med. 2006, 355:779-787.
8. Schneider H.J., Friedrich N., Klotsche J., Pieper L., Nauck M., John U., Dörr M., Felix S., Lehnert H., Pittrow D., Silber S., Völzke H., Stalla G.K., Wallaschofski H., Wittchen H.U. The predictive value of different measures of obesity for incident cardiovascular events and mortality. J. Clin. Endocrinol. Metab. 2010, 95:1777-1785. 10.1210/jc.2009-1584.
9. Fenech M. Cytokinesis-block micronucleus assay evolves into a "cytome" assay of chromosomal instability, mitotic dysfunction and cell death. Mutat. Res. 2006, 600:58-66.
10. Fenech M. Cytokinesis-block micronucleus cytome assay. Nat. Protoc. 2007, 2:1084-1104.
11. Scarpato R., Verola C., Fabiani B., Bianchi V., Saggese G., Federico G. Nuclear damage in peripheral lymphocytes of obese and overweight Italian children as evaluated by the γ-H2AX focus assay and micronucleus test. FASEB J. 2011, 25:685-693.
12. Schneider J.E., Price S., Maidt L., Gutteridge J.M., Floyd R.A. Methylene blue plus light mediates 8-hydroxy-2'-deoxyguanosine formation in DNA preferentially over strand breakage. Nucleic Acids Res. 1990, 18:631-635.
13. Kasai H. Analysis of a form of oxidative DNA damage 8-hydroxy-2'-deoxyguanosine as a marker of cellular oxidative stress during carcinogenesis. Mutat. Res. 1997, 387:146-163.
14. Floyd R.A. The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis 1990, 11:1447-1450.
15. Sato T., Takeda H., Otake S., Yokozawa J., Nishise S., Fujishima S., Orii T., Fukui T., Takano J., Sasaki Y., Nagino K., Iwano D., Yaoita T., Kawata S. Increased plasma levels of 8-hydroxydeoxyguanosine are associated with development of colorectal tumors. J. Clin. Biochem. Nutr. 2010, 47:59-63. 10.3164/jcbn.10-12.
16. Al-Aubaidy H.A., Jelinek H.F. Oxidative DNA damage and obesity in type 2 diabetes mellitus. Eur. J. Endocrinol. 2011, 164:899-904. 10.1530/EJE-11-0053.
17. Goodarzi M.T., Navidi A.A., Rezaei M., Babahmadi-Rezaei H. Oxidative damage to DNA and lipids: correlation with protein glycation in patients with type 1 diabetes. J. Clin. Lab. Anal. 2010, 24:72-76. 10.1002/jcla.20328.
18. Elwakkad A., Hassan N.M., Sibaii H., El-Zayat S., Sherif L., Hameed E.R.A., Shaheed A.A. Relationship between obesity and 8-hydroxy-2-deoxy guanosine as an oxidative marker in obese adolescents of Giza. J. Med. Sci. 2011, 11:231-235. 10.3923/jms.2011.231.235.
19. World Health Organization Waist Circumference and Waist-Hip Ratio: Report of a WHO Expert Consultation Geneva, 8-11 December 2008, Available from: http://whqlibdoc.who.int/publications/2011/9789241501491_eng.pdf (updated 2011; cited 09.07.13).
20. Fenech M. The in vitro micronucleus technique. Mutat. Res. 2000, 455:81-95.
21. Donmez-Altuntas H., Bitgen N. Evaluation of the genotoxicity and cytotoxicity in the general population in Turkey by use of the cytokinesis-block micronucleus cytome assay. Mutat. Res. 2012, 748:1-7. 10.1016/j.mrgentox.2012.05.013.
22. Eastmond D.A., Tucker J.D. Identification of aneuploidy-inducing agents using cytokinesis-blocked human lymphocytes and an antikinetochore antibody. Environ. Mol. Mutgen. 1989, 13:34-43.
23. Calle E.E., Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 2004, 4:579-591.
24. Renehan A.G., Tyson M., Egger M., Heller R.F., Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008, 371:569-578.
25. Louie S.M., Roberts L.S., Nomura D.K. Mechanisms linking obesity and cancer. Biochim. Biophys. Acta 2013, 1831:1499-1508. 10.1016/j.bbalip.2013.02.008.
26. Gandhi G., Kaur G. Assessment of DNA damage in obese individuals. Res. J. Biol. 2012, 2:37-44.
27. Tomasello B., Malfa G., Galvano F., Renis M. DNA damage in normal-weight obese syndrome measured by Comet assay. Mediterr. J. Nutr. Metab. 2011, 4:99-104. 10.1007/s12349-010-0035-6.
28. Farhangi M.A., Keshavarz S.A., Eshraghian M., Ostadrahimi A., Saboor-Yaraghi A.A. White blood cell count in women: relation to inflammatory biomarkers, haematological profiles, visceral adiposity, and other cardiovascular risk factors. J. Health Popul. Nutr. 2013, 31:58-64.
29. Barzilai A., Yamamoto K.-I. DNA damage responses to oxidative stress. DNA Repair 2004, 3:1109-1115.
30. Storr S.J., Woolston C.M., Martin S.G. Base excision repair, the redox environment and therapeutic implications. Curr. Mol. Pharmacol. 2012, 5:88-101.
31. Yesilada E., Sahin I., Ozcan H., Yildirim I.H., Yologlu S., Taskapan C. Increased micronucleus frequencies in peripheral blood lymphocytes in women with polycystic ovary syndrome. Eur. J. Endocrinol. 2006, 154:563-568.
32. Violante F.S., Sanguinetti G., Barbieri A., Accorsi A., Mattioli S., Cesari R., Fimognari C., Hrelia P. Lack of correlation between environmental or biological indicators of benzene exposure at parts per billion levels and micronuclei induction. Environ. Res. 2003, 91:135-142.
33. Kasai H., Iwamoto-Tanaka N., Miyamoto T., Kawanami K., Kawanami S., Kido R., Ikeda M. Life style and urinary 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage: effects of exercise, working conditions, meat intake, body mass index, and smoking. Jpn. J. Cancer Res. 2001, 92:9-15.
34. Loft S., Vistisen K., Ewertz M., Tjonneland A., Overvad K., Poulsen H.E. Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis 1992, 13:2241-2247.
35. Mizoue T., Tokunaga S., Kasai H., Kawai K., Sato M., Kubo T. Body mass index and oxidative DNA damage: a longitudinal study. Cancer Sci. 2007, 98:1254-1258.
36. xL international collaboration projects on human micronucleus assays in lymphocytes and buccal cells - past, present and future. Mutagenesis 2011, 26:239-245.
37. Pintus F., Floris G., Rufini A. Nutrient availability links mitochondria, apoptosis, and obesity. Aging (Albany, NY) 2012, 4:734-741.
38. Berrington de González A., Spencer E.A., Bueno-de-Mesquita H.B., Roddam A., Stolzenberg-Solomon R., Halkjaer J., Tjønneland A., Overvad K., Clavel-Chapelon F., Boutron-Ruault M.C., Boeing H., Pischon T., Linseisen J., Rohrmann S., Trichopoulou A., Benetou V., Papadimitriou A., Pala V., Palli D., Panico S., Tumino R., Vineis P., Boshuizen H.C., Ocke M.C., Peeters P.H., Lund E., Gonzalez C.A., Larrañaga N., Martinez-Garcia C., Mendez M., Navarro C., Quirós J.R., Tormo M.J., Hallmans G., Ye W., Bingham S.A., Khaw K.T., Allen N., Key T.J., Jenab M., Norat T., Ferrari P., Riboli E. Anthropometry, physical activity, and the risk of pancreatic cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol. Biomarkers Prev. 2006, 15:879-885.
39. Stolzenberg-Solomon R.Z., Adams K., Leitzmann M., Schairer C., Michaud D.S., Hollenbeck A., Schatzkin A., Silverman D.T. Adiposity, physical activity, and pancreatic cancer in the National Institutes of Health-AARP Diet and Health Cohort. Am. J. Epidemiol. 2008, 167:586-597.
40. Li D., Morris J.S., Liu J., Hassan M.M., Day R.S., Bondy M.L., Abbruzzese J.L. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA 2009, 301:2553-2562.
41. MacInnis R.J., English D.R. Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control 2006, 17:989-1003.
42. Parsons J.K., Sarma A.V., McVary K., Wei J.T. Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions. J. Urol. 2013, 189(1 Suppl.):S102-S106. 10.1016/j.juro.2012.11.029.
43. Rundle A., Jankowski M., Kryvenko O.N., Tang D., Rybicki B.A. Obesity and future prostate cancer risk among men after an initial benign biopsy of the prostate. Cancer Epidemiol. Biomarkers Prev. 2013, 22:898-904. 10.1158/1055-9965.EPI-12-0965.
44. Key T.J., Appleby P.N., Reeves G.K., Roddam A., Dorgan J.F., Longcope C., Stanczyk F.Z., Stephenson H.E., Falk R.T., Miller R., Schatzkin A., Allen D.S., Fentiman I.S., Key T.J., Wang D.Y., Dowsett M., Thomas H.V., Hankinson S.E., Toniolo P., Akhmedkhanov A., Koenig K., Shore R.E., Zeleniuch-Jacquotte A., Berrino F., Muti P., Micheli A., Krogh V., Sieri S., Pala V., Venturelli E., Secreto G., Barrett-Connor E., Laughlin G.A., Kabuto M., Akiba S., Stevens R.G., Neriishi K., Land C.E., Cauley J.A., Kuller L.H., Cummings S.R., Helzlsouer K.J., Alberg A.J., Bush T.L., Comstock G.W., Gordon G.B., Miller S.R., Longcope C. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J. Natl. Cancer Inst. 2003, 95:1218-1226. Endogenous Hormones, Breast Cancer Collaborative Group.
45. Bergstrom A., Hsieh C.C., Lindblad P., Lu C.M., Cook N.R., Wolk A. Obesity and renal cell cancer - a quantitative review. Br. J. Cancer 2001, 85:984-990.
46. Larsson S.C., Wolk A. Obesity and the risk of gallbladder cancer: a meta-analysis. Br. J. Cancer 2007, 96:1457-1461.
47. Aleksandrova K., Nimptsch K., Pischon T. Obesity and colorectal cancer. Front. Biosci. (Elite Ed.) 2013, 5:61-77.
48. Vucenik I., Stains J.P. Obesity and cancer risk: evidence, mechanisms, and recommendations. Ann. N. Y. Acad. Sci. 2012, 1271:37-43.
49. Lichtman M.A. Obesity and the risk for a hematological malignancy: leukemia, lymphoma, or myeloma. Oncologist 2010, 15:1083-1101.
50. Gu W., Chen C., Zhao K.N. Obesity-associated endometrial and cervical cancers. Front. Biosci. (Elite Ed.) 2013, 5:109-118.
51. Gilbert C.A., Slingerland J.M. Cytokines, obesity, and cancer: new insights on mechanisms linking obesity to cancer risk and progression. Annu. Rev. Med. 2013, 64:45-57.
52. Aballay L.R., Eynard A.R., Díaz Mdel P., Navarro A., Muñoz S.E. Overweight and obesity: a review of their relationship to metabolic syndrome, cardiovascular disease, and cancer in South America. Nutr. Rev. 2013, 71:168-179. 10.1111/j.1753-4887.2012.00533.x.
53. Bonassi S., Znaor A., Ceppi M., Lando C., Chang W.P., Holland N., Kirsch-Volders M., Zeiger E., Ban S., Barale R., Bigatti M.P., Bolognesi C., Cebulska-Wasilewska A., Fabianova E., Fucic A., Hagmar L., Joksic G., Martelli A., Migliore L., Mirkova E., Scarfi M.R., Zijno A., Norppa H., Fenech M. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 2007, 28:625-631.
54. Murgia E., Ballardin M., Bonassi S., Rossi A.M., Barale R. Validation of micronuclei frequency in peripheral blood lymphocytes as early cancer risk biomarker in a nested case-control study. Mutat. Res. 2008, 639:27-34.
55. Bonassi S., El-Zein R., Bolognesi C., Fenech M. Micronuclei frequency in peripheral blood lymphocytes and cancer risk: evidence from human studies. Mutagenesis 2011, 26:93-100.